Home › Trial NCT00049452
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
- Trial IDNCT00049452
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorHerbert Irving Comprehensive Cancer Center
- Enrollment120
- Start date2001-12
- ConditionsBreast Cancer · Osteoporosis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.